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A new neutral glycoside of myo-inositol was isolated from the pregnancy urine of a single donor. Its 
structure was investigated by ‘H-NMR spectroscopy and mass spectroscopy. It was identified as l-O- 
cY-2-acetamido-2-deoxy-D-galactopyranosyl-m~o-inositol. No such structure or sequence has previously 
been reported in either myo-inositol or glucose glycosides. 
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1. INTRODUCTION 
Human urine is known to contain a number of 
oligosaccharides whose excretion greatly increases 
during pregnancy and lactation [l-3]. Most of 
these saccharides have a glucose residue at their 
reducing end; they are referred to here as glucose 
glycosides. Another type of glycoside has also been 
characterized in human urine: myo-inositol 
glycosides. So far, only 5 glycosides of this type 
have been isolated - one from the urine of normal 
subjects [4,5] and 4 from pregnancy urine [6,7] - 
and a sixth was identified in human milk [8]. All 
these myo-inositol glycosides are analogous to 
glucose glycosides by substitution of a myo- 
inositol residue for the terminal glucose. 
Two of these myo-inositol glycosides are W-L- 
fucopyranosyl-myo-inositol [4,5] and 6-0-&D- 
galactopyranosyl-myo-inositol (6-&galactinol) [8]. 
However, screening of human urinary myo- 
inositol glycosides by gas chromatography/elec- 
tron impact mass spectrometry (GWEIMS) show- 
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ed that more than two glycosides containing myo- 
inositol were sometimes present [9]. 
This work reports the isolation and characteriza- 
tion of one of these compounds as I-O- 
cu-2-acetamido-2-deoxy-D-galactopyranosyl-myo- 
inositol, a sequence which has not been reported 
previously. 
2. MATERIALS AND METHODS 
Third-term pregnancy urine was collected from 
a single donor of A blood group (secretor). Urine 
was kept frozen at - 18°C until use. 
Schleicher and Schull 2043b was used for 
descending paper chromatography in the following 
solvent systems: (a) ethyl acetate/pyridine/water 
(10 : 4 : 3, v/v); (b) 1-propanol/ethyl acetate/water 
(6:1:3, v/v); (c) ethyl acetate/pyridine/acetic 
acid/water (5 : 5 : 1: 3, v/v); (d) ethyl acetate/py- 
ridine/water (12: 5:4, v/v). All papers were stain- 
ed with silver dip reagent [lo]. Monosaccharides 
and myo-inositol were analyzed by GC [ 111 under 
the conditions reported in [7]. 
‘H-NMR spectroscopy (250.13 MHz) was per- 
formed on a Bruker SY-250 spectrometer 
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operating in the pulsed Fourier transform mode at 
a probe temperature of 298 K. Chemical shifts 
were calculated in relation to sodium 
4,4’-dimethyl-4-silapentane-1-sulfonate by in- 
direct reference to acetone in 2H20 (S = 
2.225 ppm) with an accuracy of 0.15 Hz. 
The isolated myo-inositol glycoside was 
permethylated as in [12] and analyzed on a Riber- 
mag lo-10 quadripolar mass spectrometer equip- 
ped with a solid probe inlet, and using EIMS and 
direct chemical ionization (DCI) techniques. Am- 
monia was used as reactant gas @NH3 = 0.1 bar). 
For data acquisition and processing, the mass spec- 
trometer was linked to a PDP-11 system. Oper- 
ating conditions were as follows: filament current, 
20 mA; ionization energy, 90 eV; ion source 
temperature, 120°C. The myo-inositol glycoside 
was desorbed at 7 mA/s. 
Urine (1.5 1) was processed as in [7] using a col- 
umn of Sephadex G-15 fine (Pharmacia). The 
deionized fraction which contained myo-inositol 
glycosides was fractionated on a column (2.5 x 
16 cm) of DEAE-Sephadex A-25 (Pharmacia) 
equilibrated in 0.05 M pyridine acetate buffer (pH 
6.1); the column was eluted first with this buffer 
and then successively with 5 other pyridine acetate 
buffers: 0.05 M (pH 5.3), 0.1 M (pH 5.3), 0.1 M 
(pH 4.8), 0.1 M (pH 4.3) and 0.5 M (pH 4.3). The 
fraction eluted with the 0.1 M (pH 4.8) buffer con- 
tained high levels of myo-inositol (0.1 residue for 
1 glucose). It was submitted to preparative paper 
chromatography in solvent system (a) for 72 h. 
Table 1 
Chemical shifts and coupling constants observed for the isolated glycoside, and for the N-acetyl-D- 
galactosamine and la-galactinol, recorded on the same spectrometer 
Residue Proton Chemical shifts (ppm) and coupling constants (Hz) in 
Glycoside Free N-acetyl-D- 
galactosamine 
la-Galactinol 
N-Acetyl-D- 
galactosamine H-l 
H-2 
H-3 
H-4 
H-5 
H-6 
CH3CO 
la-Galactinol H-l 
H-2 
H-3 
H-4 
H-5 
H-6 
myo-Inositol H-l 
H-2 
H-3 
H-4 
H-S 
H-6 
5.46 (Jr.2 = 3.5) 5.23 (Ji. 2 = 3.7) 
4.16 (J2.3 = 9.0) 4.13 (J2 3 = 11.0) 
3.88 (J3.4 = 2.5) 3.91 (53.4 = 3.2) 
3.99 3.99 
3.95 (Js.6 = 6.0) 4.10 
n.a. 3.74 
2.05 2.04 
3.64 (31. 2 = 2.5)a 
4.24 
3.51 (J3.4 = 10.0) 
n.a. 
3.41 (J5.6 = 8.2)” 
n.a. 
5.14 (Jr.2 = 3.7) 
3.86 (52.3 = 10.1) 
3.96 (J3 4 = 3.2) 
4.01 (54.5 = 0.9) 
4.19 (J5.6 = 6.2) 
3.73 
3.63 (J, ‘2 = 2.6)a 
4.28 
3.52 (J3. 4 = 9.9)” 
3.67 
3.32 (J5.a = 9.2)a 
3.76 
a In the myo-inositol residue, JI 2 = J2.3, JI ‘6 = J3.4 and J4 5 = JS 6 
n.a., not assigned (signals for these protons could not be assigned precisely since they appeared as 
multiplet between 3.70 and 3.80 ppm) 
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The fraction with the lowest mobility appeared as 
a pure myo-inositol glycoside after filtration on a 
1.3 x 50 cm column of Biogel P-2 (200-400 mesh) 
(Bio-Rad) in 0.05 M pyridine acetate buffer (pH 
5.3). 
3. RESULTS AND DISCUSSION 
The product was homogeneous in paper 
chromatography in the 4 solvent systems (a-d); the 
respective Biactose values were: (a) 0.1, (b) 0.45, (c) 
0.24 and (d) 0.1. Monosaccharide analysis in- 
dicated the following molecular composition: N- 
acetyl-D-galactosamine to myo-inositol in molar 
ratios of 1.0: 1.0; glucose accounting for less than 
7% of the dry weight. 
The ‘H-NMR spectrum of the myo-inositol 
glycoside was compared to that of N-acetyl-D- 
galactosamine and of I-O-cY-D-galactopyranosyl- 
myo-inositol (la-galactinol) (table 1). The value 
observed for the coupling constant of the H-l of 
N-acetyl-D-galactosamine (Ji .2 = 3.5 Hz) was 
very similar to those observed for an a-type 
linkage ([13] and Davoust, D. et al., in prepara- 
tion). This suggests for our glycoside that the N- 
acetyl-D-galactosamine is also on the cy- 
configuration. The chemical shifts observed for 
the assigned protons of the myo-inositol residue 
were very similar in both the new glycoside and lcu- 
galactinol, particularly for the H-l proton (table 
I), thus suggesting the same type of linkage in the 
two compounds. 
The permethylated glycoside (MI = 509) was 
analyzed successively by EIMS and ammonia DCI: 
(i) Using EIMS, only 3 strong fragments derived 
from the myo-inositol were observed at m/z 233, 
NfRflfbWSIDFIR 
FILE CIt WS1LE11364 - 
100X= 581632 RT =OO:ll.E 
BASE SPECTRUM=468 <581632> 
ClOO, 103 0%JUL-03 
18-JAN-83 
SCAN=9 
TIC=19726784 
Fig. 1. Ammonia DC1 mass spectrum of the permethylated l-O-cy-2-acetamido-2-deoxy-D-galactopyranosyl-~~o- 
inositol (Mr = 509). Fragments at m/z 478,468 and 436 were obtained by loss of methanol, ketene and both methanol 
and ketene, respectively. 
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201 and 293 (51 fragment). Other fragments 
originating from the A-series were very weak (not 
shown); a similar phenomenon has been observed 
with different myo-inositol glycosides [5,7,9] 
although it is not fully understood. 
(ii) Using ammonia DC1 one would expect the 
100% ion peak to be at m/z (M + 18) or m/z (A4 + 
1) for a compound containing a nitrogen atom. 
The mass spectrum of the permethylated glycoside 
(fig. 1) indeed exhibited the (M + 1) ion at m/z 5 10, 
but also some other fragments originating from the 
(M + 1) ion by the loss of methanol (m/z 478), or 
of ketene (m/z 468) or both (m/z 436). The 
presence of these ions was likely a consequence of 
pyrolytic effects during the process of desorption 
of the glycoside as reported in [14]. 
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These results lead to the following structure 
assignment: 1-O--2-acetamido-2-deoxy-D-galac- 
topyranosyl-myo-inositol. 
The characterization of this new glycoside sup- 
ports our work [9] demonstrating that more than 
two neutral myo-inositol glycosides of monosac- 
charides could be present in the urine of various 
donors. 
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The structure of the new compound is of great 
interest since no such structure has previously been 
reported in myo-inositol glycosides, nor has any 
glucoside (N-acetyl-D-galactosamine-glucose or
-galactose) been characterized, even though these 
glycosides have been extensively studied [ 15,161, 
which excludes that this new compound is syn- 
thesized by the action of blood group A a-N- 
acetyl-D-galactosaminyltransferase on a myo- 
inositol acceptor. The possibility that this new 
glycoside originates from transglycosylation pro- 
cesses as reported for galactosyl inositol [17] is 
more likely. 
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